Combining Scattering Experiments and Colloid Theory to Characterize Charge Effects in Concentrated Antibody Solutions.

antibodies charge effects coarse-grained modeling effective charge

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
25 Apr 2024
Historique:
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: aheadofprint

Résumé

Charges and their contribution to protein-protein interactions are essential for the key structural and dynamic properties of monoclonal antibody (mAb) solutions. In fact, they influence the apparent molecular weight, the static structure factor, the collective diffusion coefficient, or the relative viscosity, and their concentration dependence. Further, charges play an important role in the colloidal stability of mAbs. There exist standard experimental tools to characterize mAb net charges, such as the measurement of the electrophoretic mobility, the second virial coefficient, or the diffusion interaction parameter. However, the resulting values are difficult to directly relate to the actual overall net charge of the antibody and to theoretical predictions based on its known molecular structure. Here, we report the results of a systematic investigation of the solution properties of a charged IgG1 mAb as a function of concentration and ionic strength using a combination of electrophoretic measurements, static and dynamic light scattering, small-angle X-ray scattering, and tracer particle-based microrheology. We analyze and interpret the experimental results using established colloid theory and coarse-grained computer simulations. We discuss the potential and limits of colloidal models for the description of the interaction effects of charged mAbs, in particular pointing out the importance of incorporating shape and charge anisotropy when attempting to predict structural and dynamic solution properties at high concentrations.

Identifiants

pubmed: 38661388
doi: 10.1021/acs.molpharmaceut.3c01023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Alessandro Gulotta (A)

Physical Chemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.

Marco Polimeni (M)

Physical Chemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.

Samuel Lenton (S)

Physical Chemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.

Charles G Starr (CG)

Biologics Drug Product Development and Manufacturing, CMC Development, Sanofi, Framingham, Massachusetts 01701, United States.

Anna Stradner (A)

Physical Chemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.
LINXS Institute of Advanced Neutron and X-ray Science, Scheelevägen 19, Lund SE-223 70, Sweden.

Emanuela Zaccarelli (E)

Institute for Complex Systems, National Research Council (ISC-CNR), Piazzale Aldo Moro 5, Rome 00185, Italy.
Department of Physics, Sapienza University of Rome, Piazzale Aldo Moro 2, Rome 00185, Italy.

Peter Schurtenberger (P)

Physical Chemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.
LINXS Institute of Advanced Neutron and X-ray Science, Scheelevägen 19, Lund SE-223 70, Sweden.

Classifications MeSH